Medications that will get you declined for life insurance are the ones that point to a condition most carriers will not take. The pill name is a clue. Dementia treatment, pulmonary arterial hypertension drugs, dialysis-related anemia shots, active chemotherapy, transplant anti-rejection drugs, and current opioid-replacement therapy are the files that usually end in a decline or a postpone. A statin, a blood pressure pill, or an antidepressant almost never does.
At Local Life Agents, we read the prescription history before anyone submits an application. The same drug can be a knockout on a no-exam policy and a standard or table-rated offer once a fully underwritten carrier sees why it was prescribed. We pre-screen that difference across 30+ A-rated carriers so you do not stack formal applications that create Medical Information Bureau (MIB) codes.
Key Takeaways
- The drug is a clue. Underwriters decline the condition the medication treats, not the brand name on the bottle.
- Some drugs mean decline. Dementia treatment, pulmonary hypertension drugs, dialysis, active cancer treatment, transplant drugs, and current methadone or buprenorphine usually will not clear standard fully underwritten life insurance.
- No-exam lists are longer. Simplified issue knocks out inhalers, blood thinners, and many other drugs that a fully underwritten policy can still approve.
- Everyday prescriptions are fine. Statins, blood pressure medicine, metformin, thyroid replacement, and common antidepressants are routine.
- The prescription check wins. Carriers see fills you leave off the application. A mismatch is a bigger problem than the drug.
Which medications will get you declined for life insurance?
The medications that will get you declined are the ones tied to a diagnosis most retail carriers will not price. Underwriters do not keep a secret banned-drug list for fully underwritten term and permanent life. They order a prescription check, match each fill to a condition, and apply that condition's guidelines.
- The condition — Donepezil for Alzheimer's is a different file from donepezil mentioned in an old record and stopped years ago. The diagnosis drives the decision.
- Whether you still take it — A current fill is active treatment. A drug you stopped after a finished course, such as older hepatitis C therapy, is history.
- Dose and duration — A short steroid burst is not chronic prednisone. A fentanyl patch is not a few tablets after surgery.
- The rest of the list — One blood pressure pill is routine. The same pill plus a heart-failure drug, a loop diuretic, and nitroglycerin tells a different story.
- The product type — Simplified issue (no exam, few questions) uses a knockout list. Fully underwritten coverage can ask for records and still make an offer.
If a carrier has already declined you for one of these drugs, stop applying and read what to do after a life insurance decline before the next MIB entry.
Which medications usually mean a life insurance decline?
These are the red-flag medications from our original decline list, plus drugs that have become standard signals since then. "Decline" here means most fully underwritten carriers will not offer individual life insurance while you are on the drug or the condition is active. It is not a promise that every company says no, and it is not a forever ban after the condition changes.
The groups that matter most are cognitive impairment, pulmonary arterial hypertension, dialysis, active cancer treatment, organ transplant, and current medication-assisted treatment for opioid dependence.
| Medication | Condition it signals | Usual fully underwritten result |
|---|---|---|
| Antabuse (disulfiram) | Alcohol use disorder | Postpone during treatment. Documented sobriety can be insurable later. |
| Campral (acamprosate) | Alcohol use disorder | Same as Antabuse. The treatment history is the underwriting issue. |
| Depade, ReVia, or Vivitrol (naltrexone) | Alcohol or opioid use disorder | Postpone while you are on it. Time sober decides the next offer. |
| Suboxone (buprenorphine and naloxone) or Sublocade | Opioid dependence | Many carriers decline while you are on agonist therapy. |
| Methadone | Opioid dependence or severe chronic pain | Usually a decline on standard fully underwritten term while in use. |
| Aricept (donepezil) | Alzheimer's or other dementia | Decline at most carriers. |
| Cognex (tacrine) | Alzheimer's | Decline. Rarely prescribed now. An old fill is still a cognitive-impairment flag. |
| Exelon (rivastigmine) | Alzheimer's or Parkinson's dementia | Decline when prescribed for dementia. |
| Namenda (memantine) | Alzheimer's or other dementia | Decline at most carriers. |
| Razadyne (galantamine) | Alzheimer's or other dementia | Decline at most carriers. |
| Leqembi (lecanemab) or Kisunla (donanemab) | Alzheimer's | Decline. These are newer anti-amyloid drugs. |
| Aranesp (darbepoetin) | Anemia from kidney failure, dialysis, or chemotherapy | Decline on dialysis. Cancer use follows remission rules. |
| Epogen or Procrit (epoetin alfa) | Dialysis or chemotherapy-related anemia | Same as Aranesp. The indication matters more than the brand. |
| Flolan (epoprostenol) | Pulmonary arterial hypertension | Decline. |
| Remodulin (treprostinil) | Pulmonary arterial hypertension | Decline. |
| Ventavis (iloprost) | Pulmonary arterial hypertension | Decline. |
| Tracleer (bosentan) | Pulmonary arterial hypertension | Decline. |
| Opsumit, Letairis, Adempas, Uptravi, or Tyvaso | Pulmonary arterial hypertension | Decline. Newer PAH drugs, same result as the older infusions. |
| Entresto (sacubitril and valsartan) | Heart failure | Decline or a heavy table rating at most carriers. |
| Clozapine (Clozaril) | Treatment-resistant schizophrenia | Decline at most carriers. |
| Morphine, a fentanyl patch, or other chronic high-dose opioids | Severe chronic pain or opioid dependence | Often a decline or postpone. Diagnosis and dose decide it. |
| Tacrolimus (Prograf) or mycophenolate (CellCept) | Organ transplant | Decline at most retail carriers. |
| Home oxygen | Advanced lung or heart disease | Decline. |
Dialysis and chemotherapy-related anemia drugs belong with kidney disease underwriting and life insurance after cancer. A completed course of chemo is a waiting-period question. Being on chemo now is a postpone.
Which medications decline simplified issue life insurance?
Simplified issue life insurance declines a longer medication list because there is no exam and often no medical records. Any drug below is a common knockout on no-exam applications. Many of those same drugs are still insurable when you apply for fully underwritten coverage and the carrier can see the diagnosis. No-medical-exam life insurance is the faster path only when your prescriptions are not on that knockout list.
This chart is the simplified-issue list from our original page, plus drugs that show up on newer no-exam knockouts. Blood thinners, inhalers, and HIV treatment are the rows people misread as a ban on all life insurance.
| Medication | Why it shows up on no-exam lists | Fully underwritten outlook |
|---|---|---|
| Advair, Combivent, or Spiriva | COPD or harder-to-control asthma | Often a rating, not an automatic decline, if lung tests are stable. |
| Copaxone or Avonex | Multiple sclerosis | Rated on MS type, progression, and disability. Not an automatic decline. |
| Evista (raloxifene) | Osteoporosis or breast-cancer risk reduction | Usually a minor factor once the reason is documented. |
| Lanoxin, Digitek, or Digoxin | Heart failure or a rhythm problem | Often a decline or a heavy table rating. |
| Risperdal, Haldol, or Zyprexa | Psychosis, bipolar disorder, or severe depression | Depends on the diagnosis, hospitalizations, and stability. |
| Zidovudine (AZT), Crixivan, Epivir, or Sustiva | HIV treatment | Knockout on many no-exam apps. Fully underwritten HIV is a separate decision. |
| Aggrenox, Coumadin, Warfarin, Plavix, or Heparin | Prior clot, stent, atrial fibrillation, or a valve | The reason you take it decides the offer. |
| Eliquis, Xarelto, or Pradaxa | Same clot and heart indications as warfarin | Newer no-exam knockouts. Fully underwritten carriers still review the cause. |
| Lasix or furosemide | Fluid retention from heart, kidney, or liver disease | The cause decides it. Ankle swelling is not the same file as heart failure. |
| Sinemet, Requip, or Eldepryl | Parkinson's disease | Stage and function decide a rating or a decline. |
| Zofran (ondansetron) | Nausea, often during cancer treatment | The cancer timeline matters. The anti-nausea drug alone does not. |
| Amiodarone | Serious heart-rhythm disease | Often a decline or postpone until the workup is stable. |
| Femara, Lupron, or Tamoxifen | Hormone therapy tied to cancer | Waiting period after treatment. Not a lifetime decline. |
| Depakote | Seizures or bipolar disorder | Rated on the diagnosis, control, and time since the last event. |
| Nitroglycerin or isosorbide dinitrate | Angina or coronary disease | A cardiac workup decides postpone, table rating, or decline. |
| Baclofen | Spasticity from MS or a spinal condition | Rated on the underlying condition. |
| Infergen or ribavirin | Older hepatitis C treatment | A cured infection is often insurable. Active liver disease is not. |
| Xeloda or Tarceva | Active or recent cancer treatment | Postpone until remission rules are met. |
| Aricept, Exelon, Cognex, or morphine | Dementia or chronic opioids | Usually a decline. Same result as the fully underwritten list above. |
| Insulin | Diabetes on many no-exam products | Fully underwritten diabetes can still be approved. Insulin is not a ban. |
| Home oxygen, methadone, or a fentanyl patch | Advanced disease or opioid treatment | Decline or postpone on both no-exam and most fully underwritten plans. |
Inhalers such as Advair and Spiriva belong on the COPD underwriting page, not on a banned-drug list. HIV antivirals on a no-exam knockout list are not the same decision as life insurance with HIV when viral load is controlled. Antipsychotics are read with the depression and mental health file: one antipsychotic is not an automatic fully underwritten decline, and clozapine usually is.
A table rating is an approval at a higher price. Life insurance rate classes explain how Preferred, Standard, and tables differ once a carrier is willing to offer.
Which prescriptions rarely get you declined?
Most daily medications never show up as a decline reason. Underwriters expect them. Leaving them off the application is what creates the problem, because the prescription check will list them anyway.
- Statins — Atorvastatin, rosuvastatin, and simvastatin for cholesterol are routine.
- Blood pressure pills — Lisinopril, losartan, amlodipine, and similar drugs are routine when readings are controlled.
- Metformin — First-line type 2 diabetes treatment. The A1C and complications matter, not the fact of the pill.
- Thyroid replacement — Levothyroxine for hypothyroidism is not a rated impairment at most carriers.
- Common antidepressants — Sertraline, escitalopram, and similar SSRIs for stable depression or anxiety are usually Standard or better.
A rescue inhaler such as albuterol, used alone, is in the same category. The life insurance medical exam and the prescription report are where these fills get confirmed.
Expert Tip: Read the reason, not the bottle
I pull the prescription check before I read the application. Lasix after a long flight is not Lasix for a weak heart. Nitroglycerin in a cabinet from 2014 is not nitroglycerin refilled last month. I will not submit a formal application until we know which file we actually have, because the wrong application is the one that creates the MIB code.
—Ryan Wood
What should you do if a medication may decline you?
If your drug is on the decline list, do not fill out three applications this week to see who says yes. Each formal application can be reported to the MIB whether you are approved or not.
- List every current fill — Include mail-order, samples you later filled, and drugs a specialist prescribed.
- Write the reason — One line per drug: who prescribed it, the diagnosis, and whether you still take it.
- Match the product — If the drug is only a no-exam knockout, fully underwritten coverage is the path. If it is a true decline drug, a no-exam app will not fix it.
- Pre-screen before you apply — An informal review asks how a carrier would treat the drug without opening a formal file.
- Apply once — Submit where the pre-screen was favorable. If fully underwritten coverage is closed, look at guaranteed issue life insurance rather than another declined application.
Bring the medication list and the diagnosis in one pass. That is the comparison that tells us whether to shop fully underwritten coverage or stop.
Conclusion
Carrier guidelines split on the drugs that are not automatic declines. One company tables an inhaler, a blood thinner, or a psychiatric medication. Another postpones the same list. We know which of those niches are real because we place the cases, and we say so before a formal application exists. Dementia treatment, pulmonary hypertension drugs, dialysis, active cancer treatment, and current opioid-replacement therapy are the files where most retail carriers say no.
When a medication is on your record, we pre-screen the prescription check informally and submit one application where the guideline fits. If that door is closed, we say so and look at simplified or guaranteed issue instead of hoping the next carrier did not see the last decline. Start with the drug and the reason it was prescribed. Our life insurance underwriting guides cover the conditions behind these medications. The life insurance hub covers the products those offers land on.
FAQ
Life Insurance
See what you'd pay — run your numbers across 30+ A-rated carriers in about 2 minutes.
Run My Numbers